Menu

MRC Clinical Trials Unit at UCL

The UKRI logo on the left features a combination of text and geometric shapes. On the left side, the bold white letters UKRI stand out against a dark blue background. Adjacent to it, two overlapping squares — one dark blue and one light blue — create a layered effect. Next to it, MRC Clinical Trials Unit is written in dark blue against a white background. On the right is the UCL logo. It is black with white text and includes an image of an iconic building structure.

UCL's MRC Clinical Trials Unit (MRC CTU) aims to answer key questions in infectious diseases and cancer, and to speed up the translation of scientific research into patient benefits.

We design and conduct clinical trials, and we combine the results of several trials that address the same disease or condition (this is called a systematic review or meta-analysis). We also carry out observational studies to assess the impact of new interventions in routine care.

Our research helps to improve healthcare in the UK and around the world.

The MRC Clinical Trials Unit at UCL has about 200 staff and is currently co-ordinating approximately 60 trials and meta-analyses.

The MRC Clinical Trials Unit is a UKCRC registered trials unit and is part of the Institute of Clinical Trials and Methodology in the UCL School of Life and Medical Sciences.

 

Get in touch